Home | Careers | Contact Us | Client Log-in | News | RSS Feed
  • About Us
    • Corporate Overview
    • Leadership Team
    • Scientific Advisory Board
    • Manager Members
    • Contact Us
  • Therapeutic Expertise
    • Cardiovascular & Thoracic
    • Central Nervous System
    • Gastrointestinal
    • Medical Device
    • Musculoskeletal
    • Oncology
  • Radiology Team
  • Imaging Core Lab Services
  • Technology
  • Quality
    • FDA Audited
    • ISO 9001:2008 Certified
    • ISO 13485:2003 Certified
    • GAMP 5 Implementation
    • Quality Policy
    • ABAC Policy
    • Quality Metrics
  • Publications
Share |
Follow Me!

Clinical Trial Inquiries

Todd Joron, BSc, MBA

Todd.Joron@IntrinsicCRO.com

Tel : +1-978-549-4971

 


Central Nervous System


Intrinsic Imaging radiologists are deeply involved in the diagnosis and treatment of central nervous system disorders and review approximately 400,000 CNS images annually.


Our team of 7 full time time fellowship trained CAQ board certified neuroradiologists specializes in all brain and spine pathology with broad experience and expertise in MRI, CT, diagnostic and interventional angiographic procedures, as well as PET imaging using novel CNS markers.

 

Clinical trials involving disorders of the Central Nervous System (CNS) present a number of challenges. A wealth of domain knowledge utilizing validated scoring methods in centralized image processing and analysis for all necessary modalities and techniques is required.

At Intrinsic Imaging, we are dedicated to the treatment of Central Nervous System disorders. Our expertise includes, but is not limited to;

  • Tumors with novel measurement techniques
  • Alzheimer's and variants
  • Parkinson’s including dyskinesias
  • Spinal degenerative diseases with spinal cord injury
  • Demyelinating inflammatory diseases Multiple Sclerosis and polyneuropathies
  • Aneurysm and vascular malformations
  • Neurointerventional Devices

Further, Intrinsic Imaging neuroradiology expertise includes, but is not limited to;

  • Expertise including but not limited to the full complement of brain and spine disease processes with special emphasis on vascular diseases.

  • Multiple modality expertise including: ultrasound, nuclear imaging, PET, invasive angiography, MR, and CT including novel techniques such as functional MRI, MTR, and perfusion.

  • Expertise in adults and pediatrics.

  • Extensive expertise in the interpretation of complex trauma imaging in TBI.

  • Stroke evaluation and treatment including diffusion and perfusion imaging with subsequent intravenous and intra-arterial thrombectomy and thrombolysis.

  • Ultrasound, CTA, MRA and catheter angiography for quantifying percent stenosis of the carotid bifurcation by the NASCET criteria.

  • Alzheimer’s disease analysis with quantitative PET, CT and evaluation using sub-segmentation of the cerebralcortex including gray and white matter volumes as well as hippocampal volumes.

  • Evaluation and treatment of cerebral aneurysms, arteriovenous malformations (AVM’s) and dural arteriovenous fistulas (DAVF’s) with CTA, MRA and catheter angiography

  • Preoperative imaging with functional MRI (fMRI), diffusion tensor imaging (DTI), perfusion, spectroscopy and surface rendering of the cortex and cortical venous anatomy.

  • Quantitative CSF flow analysis for Normal Pressure Hydrocephalus (communicating hydrocephalus) and obstructive hydrocephalus.

  • Subspecialty interpretation of CT and MRI of spinal degenerative disease.

James Dix, M.D., Medical Director, Neurology and Neurological Imaging
Dr. Dix is a graduate of Georgia State University and attended medical school at Emory University. He completed his radiology residency at the University of Washington in Seattle before his 2 year neuroradiology fellowship at the University of Virginia. Dr. Dix has authored multiple peer reviewed articles on neuroradiology and neurosurgery. He has developed and published innovative techniques in percutaneous cement fixation of sacral and pelvic fractures. He lectures nationally on advanced imaging techniques for radiologists and neurosurgeons. He is board-certified in radiology and possesses a certificate of added qualification (CAQ) in neuroradiology.

Recent News

 

04/08/2013 - Intrinsic Imaging Appoints Dr. Reta Rupich as Vice President, Medical Imaging Operations

 

03/13/2013 - Intrinsic Imaging Awarded Large 5 Year International Phase II Clinical Trial to Treat Iron Overloaded Patients

 

02/27/2013 - Neurological Imaging: Contrast Enhancement in Clinical Trials

 

02/26/2013 - Intrinsic Imaging Expands Operations - Opens Medical Imaging Campus in Greater Boston

 

01/17/2013 - Imaging Analysis and Operative Treatment of Diaphyseal Fractures

 

09/24/2012 - Intrinsic Imaging Obtains ISO 13485 Medical Device Certification

 

09/18/2012 - Intrinsic Imaging Awarded International Phase III Clinical Trial for Novel Orthopedic Medical Device

 

08/23/2012 - Tissue Iron Deposition : MRI Quantitation in Clinical Trials

 

08/21/2012 - Intrinsic Imaging Awarded Large International Phase III Clinical Trial for the Treatment of Severe Traumatic Brain Injury

 

08/07/2012 - Intrinsic Imaging Undergoes Extensive FDA Audit - Receives Zero 483 Observations

 

07/18/2012 - Intrinsic Imaging Awarded International Phase III Clinical Trial for Cystic Fibrosis

 

07/09/2012 - Echocardiography : Advantages in Clinical Trials

 

07/05/2012 - Orthopedic Device Assessments : Medical Imaging Challenges in Clinical Trials

 

07/03/2012 - Traumatic Brain Injury: Medical Imaging in Clinical Trials

 

06/20/2012 - Intrinsic Imaging Awarded Phase II Trial of Novel Therapy for Patients with Treatment-Resistant Metastatic Pancreatic or Colorectal Cancer

 

06/03/2012 - Advances in Imaging of Rheumatoid Arthritis

 

04/17/2012 - Metastatic Colorectal Cancer and Locoregional Therapies

 

03/20/2012 - Intrinsic Imaging Core Lab Expertise Contributes to FDA Clearance of Neurointerventional Medical Device

 

03/08/2012 - Quantitative Neuroimaging of Alzheimer’s Disease

 

03/06/2012 - Intrinsic Imaging Implements ISPE GAMP 5

 

01/31/2012 - Intrinsic Imaging Awarded Cardiovascular Clinical Trial

 

01/10/2012 - Intrinsic Imaging Awarded Important Clinical Trial for the Evaluation of Breast Cancer

 

12/15/2011 - WHO, RECIST, mRECIST, Cheson, EASL : The Challenges of Evaluating Tumor Response With The Evolution of Novel Biologics

 

More News >

 

Cardiology
Neurology
Oncology
Orthopedics
Osteoporosis
Osteoarthritis
Rheumatoid Arthritis
Protocol Design
Imaging Charter
Site Qualification
Site Training
Imaging Acquisition
Image Processing
Image Analysis

Quality Control
Data Management
Regulatory compliance
© Copyright 2000-2011